| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 5 buys and 12 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2020 | Berns Paul L | Director | Sell | 931 | $125.87 | $117,185.44 | -8.7% | |
| Jun 5, 2020 | Carr Patricia65 | VP, Finance &Pao | Sell | 138 | $124.00 | $17,112.00 | -2.1% | |
| May 27, 2020 | Mulligan Seamus | Director | Buy | 50,000 | $111.08 | $5,553,804.93 | +0.9% | |
| Mar 12, 2020 | Carr Patricia65 | VP, Finance &Pao | Sell | 600 | $102.17 | $61,302.00 | -8.5% | |
| Mar 12, 2020 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 1,500 | $102.17 | $153,255.00 | -6.4% | |
| Mar 9, 2020 | Larkin Finbar61 | SVP, Technical Operations | Sell | 907 | $113.96 | $103,358.79 | -3.1% | |
| Mar 9, 2020 | Carr Patricia65 | VP, Finance &Pao | Sell | 800 | $113.69 | $90,950.70 | -5.1% | |
| Mar 4, 2020 | Carr Patricia65 | VP, Finance &Pao | Sell | 500 | $119.20 | $59,601.74 | -3.0% | |
| Mar 3, 2020 | Larkin Finbar61 | SVP, Technical Operations | Sell | 279 | $119.75 | $33,410.22 | -1.9% | |
| Feb 13, 2020 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 1,500 | $142.18 | $213,270.00 | -5.3% |